BIOMERIEUX (BIM.PA) Stock Price & Overview
EPA:BIM • FR0013280286
The current stock price of BIM.PA is 95.4 EUR. Today BIM.PA is up by 0.16%. In the past month the price increased by 0.63%. In the past year, price decreased by -17.26%.
BIM.PA Key Statistics
- Market Cap
- 11.292B
- P/E
- 24.72
- Fwd P/E
- 19.06
- EPS (TTM)
- 3.86
- Dividend Yield
- 0.93%
BIM.PA Stock Performance
BIM.PA Stock Chart
BIM.PA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to BIM.PA. When comparing the yearly performance of all stocks, BIM.PA is a bad performer in the overall market: 85.97% of all stocks are doing better.
BIM.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to BIM.PA. BIM.PA has an excellent financial health rating, but there are some minor concerns on its profitability.
BIM.PA Earnings
On November 4, 2025 BIM.PA reported an EPS of 1.35 and a revenue of 2.04B. The company missed EPS expectations (-39.79% surprise) and missed revenue expectations (-2.12% surprise).
BIM.PA Forecast & Estimates
17 analysts have analysed BIM.PA and the average price target is 121.1 EUR. This implies a price increase of 26.94% is expected in the next year compared to the current price of 95.4.
For the next year, analysts expect an EPS growth of 15.89% and a revenue growth 3.68% for BIM.PA
BIM.PA Groups
Sector & Classification
BIM.PA Financial Highlights
Over the last trailing twelve months BIM.PA reported a non-GAAP Earnings per Share(EPS) of 3.86. The EPS decreased by -8.45% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.17% | ||
| ROA | 7.04% | ||
| ROE | 9.61% | ||
| Debt/Equity | 0.09 |
BIM.PA Ownership
BIM.PA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 2M6 | MEDTRONIC PLC | 14.75 | 103.215B | ||
| SHL | SIEMENS HEALTHINEERS AG | 15.11 | 45.684B | ||
| 1PHIA | KONINKLIJKE PHILIPS NV | 17.51 | 25.662B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 16.36 | 24.632B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 16.42 | 24.555B | ||
| DIA | DIASORIN SPA | 16.86 | 3.845B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 18.63 | 3.66B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 10.61 | 2.27B | ||
| DRW3 | DRAEGERWERK AG - PREF | 11.95 | 1.653B | ||
| DRW8 | DRAEGERWERK AG | 9.87 | 1.343B | ||
| ELN | EL.EN. SPA | 21.21 | 1.065B | ||
| EUZ | ECKERT & ZIEGLER SE | 18.11 | 952.165M |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About BIM.PA
Company Profile
bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. The company is headquartered in Craponne, Auvergne-Rhone-Alpes and currently employs 14,754 full-time employees. The company went IPO on 2004-06-07. The firm designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The firm also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.
Company Info
BIOMERIEUX
376, chemin de l'Orme
Craponne AUVERGNE-RHONE-ALPES FR
Employees: 14451
Phone: 33478872000
BIOMERIEUX / BIM.PA FAQ
What does BIOMERIEUX do?
bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. The company is headquartered in Craponne, Auvergne-Rhone-Alpes and currently employs 14,754 full-time employees. The company went IPO on 2004-06-07. The firm designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The firm also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.
What is the stock price of BIOMERIEUX today?
The current stock price of BIM.PA is 95.4 EUR. The price increased by 0.16% in the last trading session.
Does BIM stock pay dividends?
BIOMERIEUX (BIM.PA) has a dividend yield of 0.93%. The yearly dividend amount is currently 0.85.
What is the ChartMill technical and fundamental rating of BIM stock?
BIM.PA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Is BIOMERIEUX (BIM.PA) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BIM.PA.
Can you provide the number of employees for BIOMERIEUX?
BIOMERIEUX (BIM.PA) currently has 14451 employees.
Can you provide the ownership details for BIM stock?
You can find the ownership structure of BIOMERIEUX (BIM.PA) on the Ownership tab.